ClinVar Miner

Submissions for variant NM_032043.2(BRIP1):c.1619A>T (p.Gln540Leu) (rs4988349)

Minimum review status: Collection method:
Minimum conflict level:
ClinVar version:
Total submissions: 7
Download table as spreadsheet
Submitter RCV SCV Clinical significance Condition Last evaluated Review status Method Comment
Ambry Genetics RCV000131607 SCV000186623 uncertain significance Hereditary cancer-predisposing syndrome 2018-09-25 criteria provided, single submitter clinical testing Insufficient or conflicting evidence
GeneDx RCV000222534 SCV000279288 uncertain significance not provided 2018-09-24 criteria provided, single submitter clinical testing This variant is denoted BRIP1 c.1619A>T at the cDNA level, p.Gln540Leu (Q540L) at the protein level, and results in the change of a Glutamine to a Leucine (CAA>CTA). This variant was identified in one BRCA1/2 negative individual with a personal and family history of breast cancer; however it was not found in three other affected relatives (Rutter 2003). BRIP1 Gln540Leu was not observed at a significant allele frequency in large population cohorts (Lek 2016). BRIP1 Gln540Leu is not located in a known functional domain. In-silico analysis, which includes protein predictors and evolutionary conservation, supports a deleterious effect. Based on currently available evidence, it is unclear whether BRIP1 Gln540Leu is a pathogenic or benign variant. We consider it to be a variant of uncertain significance.
Invitae RCV000465039 SCV000547258 uncertain significance Familial cancer of breast; Fanconi anemia, complementation group J 2019-12-25 criteria provided, single submitter clinical testing This sequence change replaces glutamine with leucine at codon 540 of the BRIP1 protein (p.Gln540Leu). The glutamine residue is moderately conserved and there is a moderate physicochemical difference between glutamine and leucine. This variant is present in population databases (rs4988349, ExAC 0.001%). This variant has been reported in an individual affected with breast cancer, but neither the proband s daughter, nor her two nieces who had breast cancer carried this variant (PMID: 12872252). ClinVar contains an entry for this variant (Variation ID: 142473). Algorithms developed to predict the effect of missense changes on protein structure and function do not agree on the potential impact of this missense change (SIFT: "Deleterious"; PolyPhen-2: "Benign"; Align-GVGD: "Class C0"). In summary, the available evidence is currently insufficient to determine the role of this variant in disease. Therefore, it has been classified as a Variant of Uncertain Significance.
Counsyl RCV000662789 SCV000785598 uncertain significance Fanconi anemia, complementation group J; Neoplasm of ovary 2017-10-04 criteria provided, single submitter clinical testing
Fulgent Genetics,Fulgent Genetics RCV000465039 SCV000895111 uncertain significance Familial cancer of breast; Fanconi anemia, complementation group J 2018-10-31 criteria provided, single submitter clinical testing
Color RCV000131607 SCV000910891 likely benign Hereditary cancer-predisposing syndrome 2016-07-12 criteria provided, single submitter clinical testing
Integrated Genetics/Laboratory Corporation of America RCV000781166 SCV000919045 uncertain significance not specified 2017-11-24 criteria provided, single submitter clinical testing Variant summary: The BRIP1 c.1619A>T (p.Gln540Leu) variant involves the alteration of a conserved nucleotide and 2/4 in silico tools predict a benign outcome for this variant (SNPsandGO not captured due to low reliability index). However, these predictions have yet to be functionally assessed. This variant was found in 7/349872 control chromosomes (gnomAD), predominantly observed in the Ashkenazi Jewish subpopulation at a frequency of 0.000712 (7/9838). This frequency is about 11 times the estimated maximal expected allele frequency of a pathogenic BRIP1 variant (0.0000625), suggesting this is likely a benign polymorphism found primarily in those of Ashkenazi Jewish origin. A publication, Rutter_2003, indicates the variant was found in a Breast Cancer family, which three affected family members did not carry the variant of interest showing lack of cosegregation. In addition, multiple clinical diagnostic laboratories/reputable databases classified this variant as uncertain significance. Taken together, this variant is classified as a "Variant of Uncertain Significance - Possibly Benign."

The information on this website is not intended for direct diagnostic use or medical decision-making without review by a genetics professional. Individuals should not change their health behavior solely on the basis of information contained on this website. Neither the University of Utah nor the National Institutes of Health independently verfies the submitted information. If you have questions about the information contained on this website, please see a health care professional.